Our data combined with the results of the transgenic Adamdec1 knockout phenotype indicate that induction of Adamdec1 may be a secondary defensive response to inflammation and that increased ADAMDEC1 contributes to loss of PDGFRα+ cells in DSS-induced colitis. The gene discussed is ADAMDEC1; the disease is colitis.